Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, Node Positive, HR+/HER2- Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: Ribociclib;   Radiation: Postoperative Radiation Therapy Sponsor:   University of Michigan Rogel Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials